Avion Healthcare Pvt. Ltd. is an established pharmaceutical company based in Chandigarh, offering Pharma Franchise opportunities for Injections and a diversified portfolio of healthcare products. Established in 2019, the company provides pharmaceutical tablets, capsules, syrups, suspensions, injections, ointments, softgels, and other formulations for healthcare professionals, distributors, and pharmaceutical business partners.
The company's injectable portfolio includes formulations such as Ceftriaxone, Ceftriaxone with Sulbactam, Amikacin, Iron Sucrose, Pantoprazole, Triamcinolone, and Methylcobalamin injections. This range covers important therapeutic areas including antibiotics, gastroenterology, nutritional support, pain and inflammation management, and other healthcare requirements.
Avion Healthcare provides PCD Pharma Franchise and pharmaceutical third-party manufacturing services to business associates across India. Its franchise model is supported by product availability, marketing assistance, promotional support, and a wide distribution network. The company also states that it follows a stringent quality-control approach and operates as an ISO 9001:2015 certified company.
With a diverse pharmaceutical portfolio, dedicated injectable range, experienced professionals, and customer-focused business practices, Avion Healthcare continues to expand its presence in the Indian pharmaceutical market. Its injectable portfolio and franchise services make it a suitable option for entrepreneurs searching for a Pharma Franchise Company for Injections in India.
Avion Healthcare emphasizes stringent quality-control processes and quality-focused pharmaceutical practices to maintain the safety, purity, consistency, and reliability of its injectable products.
To provide quality pharmaceutical and injectable products while supporting franchise partners through reliable supply, professional marketing assistance, ethical practices, and customer-focused business solutions.
To become a trusted pharmaceutical franchise partner by expanding its injectable portfolio, strengthening distribution networks, and delivering dependable healthcare products across India.
N/A